Group ALS (-4,+1d) CsA (0-20d) GFP+-ASC (+7,+10,+14) Allograft survival day
1 9, 9, 11, 8, 10, 14
2 105*, >150, >150, >150, >150, >150
*Expired during sampling, but no rejection of allograft
Table 1: Analysis of allo-transplant survival days in a rodent hind-limb VCA model.